Preclinical Evaluation of the PARP Inhibitor, Olaparib, in Combination With Cytotoxic Chemotherapy in Pediatric Solid Tumors
Pediatric Blood and Cancer - United States
doi 10.1002/pbc.24697
Full Text
Open PDFAbstract
Available in full text
Date
September 4, 2013
Authors
Publisher
Wiley